Physician profile
James B Ross
NPI 1659324721
$18,156.04
in general payments reported to CMS, 2019-2025
56 companies · $3,324 in 2025
The $3,324 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,271 · 2020: $1,465 · 2021: $1,872 · 2022: $3,520 · 2023: $3,006 · 2024: $2,698 · 2025: $3,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,027.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,400.97 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,685.60 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $1,564.76 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $1,296.05 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $1,118.12 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $909.97 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $851.40 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $734.79 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Mallinckrodt Hospital Products INC. | $724.44 | 2020-2025 | Acthar |
| Genentech USA, INC. | $612.77 | 2019-2025 | Xolair |
| Insmed, INC. | $558.94 | 2019-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $488.29 | 2019-2025 | Smartvest |
| Ani Pharmaceuticals, INC. | $394.85 | 2022-2025 | Purified Cortrophin Gel |
| Jazz Pharmaceuticals INC. | $389.73 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $374.28 | 2019-2021 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $363.51 | 2020-2025 | Glassia |
| Baxter Healthcare | $291.41 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $284.09 | 2019-2025 | Dreamwear, (Di7) Home Pi Undivided |
| Biogen, INC. | $274.39 | 2019-2023 | Spinraza |
| Harmony Biosciences LLC | $247.91 | 2020-2025 | Wakix |
| Pulmonx Corporation | $246.71 | 2020-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Merck Sharp & Dohme LLC | $230.51 | 2019-2025 | Zerbaxa, Winrevair, Recarbrio |
| Amgen INC. | $189.31 | 2022-2025 | Tezspire |
| Advanced Respiratory, INC | $188.47 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $183.54 | 2019-2025 | |
| Verona Pharma, INC. | $178.10 | 2025 | Ohtuvayre |
| Stryker Corporation | $146.41 | 2025 | Triton Canister System |
| Grifols USA, LLC | $142.87 | 2019-2025 | Prolastin-C Liquid |
| Zoll Respicardia, INC. | $123.98 | 2023-2025 | Remede System |
| Gilead Sciences, INC. | $103.88 | 2019 | |
| Abbvie INC. | $98.75 | 2021-2023 | Avycaz |
| Viatris Specialty LLC | $91.80 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $65.29 | 2019-2023 | Airduo Digihaler |
| Mallinckrodt Enterprises LLC | $52.67 | 2019 | |
| Ucb, INC. | $52.03 | 2019-2021 | |
| Circassia INC. | $49.20 | 2019-2020 | |
| Shionogi INC | $46.28 | 2022-2025 | Fetroja |
| Paratek Pharmaceuticals, INC. | $37.82 | 2021-2022 | |
| Lilly USA, LLC | $31.90 | 2025 | Zepbound |
| Pharming Healthcare, INC. | $29.71 | 2022 | |
| Idorsia Pharmaceuticals US INC | $28.85 | 2023 | Quviviq |
| Vifor Pharma, INC. | $27.26 | 2024 | Zemaira |
| Covis Pharma Gmbh | $26.18 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $22.63 | 2023 | Lumryz |
| Inogen, INC. | $21.14 | 2024 | |
| Vanda Pharmaceuticals INC. | $21.13 | 2021 | |
| Csl Behring | $20.49 | 2021 | |
| Inspire Medical Systems, INC. | $19.86 | 2023 | Inspire |
| Phadia US INC. | $19.43 | 2023 | Immunocap |
| Shire North American Group INC | $19.36 | 2019 | |
| Abiomed | $18.60 | 2025 | |
| Nabriva Therapeutics, Plc | $15.88 | 2022 | |
| Veran Medical Technologies, INC. | $15.32 | 2020 | |
| Itamar Medical INC | $13.12 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.29 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.